216 related articles for article (PubMed ID: 24488492)
1. The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer.
Jangani M; Poolman TM; Matthews L; Yang N; Farrow SN; Berry A; Hanley N; Williamson AJ; Whetton AD; Donn R; Ray DW
J Biol Chem; 2014 Mar; 289(13):8931-46. PubMed ID: 24488492
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels.
Yan D; Zheng X; Tu L; Jia J; Li Q; Cheng L; Wang X
Mol Med Rep; 2015 Jan; 11(1):295-302. PubMed ID: 25352209
[TBL] [Abstract][Full Text] [Related]
3. The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis.
Nakazawa Y; Arai H; Fujita N
Cancer Res; 2011 Feb; 71(3):1146-55. PubMed ID: 21148752
[TBL] [Abstract][Full Text] [Related]
4. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
5. Interferon-inducible factor 16 is a novel modulator of glucocorticoid action.
Berry A; Matthews L; Jangani M; Plumb J; Farrow S; Buchan N; Wilson PA; Singh D; Ray DW; Donn RP
FASEB J; 2010 Jun; 24(6):1700-13. PubMed ID: 20086048
[TBL] [Abstract][Full Text] [Related]
6. The anticancer plant triterpenoid, avicin D, regulates glucocorticoid receptor signaling: implications for cellular metabolism.
Haridas V; Xu ZX; Kitchen D; Jiang A; Michels P; Gutterman JU
PLoS One; 2011; 6(11):e28037. PubMed ID: 22132201
[TBL] [Abstract][Full Text] [Related]
7. Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells.
Kay P; Schlossmacher G; Matthews L; Sommer P; Singh D; White A; Ray D
PLoS One; 2011; 6(10):e24839. PubMed ID: 21984896
[TBL] [Abstract][Full Text] [Related]
8. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
Waters CE; Stevens A; White A; Ray DW
J Endocrinol; 2004 Nov; 183(2):375-83. PubMed ID: 15531725
[TBL] [Abstract][Full Text] [Related]
9. CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform.
Tliba O; Cidlowski JA; Amrani Y
Mol Pharmacol; 2006 Feb; 69(2):588-96. PubMed ID: 16291871
[TBL] [Abstract][Full Text] [Related]
10. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages.
Rollins DA; Kharlyngdoh JB; Coppo M; Tharmalingam B; Mimouna S; Guo Z; Sacta MA; Pufall MA; Fisher RP; Hu X; Chinenov Y; Rogatsky I
Nat Commun; 2017 Nov; 8(1):1739. PubMed ID: 29170386
[TBL] [Abstract][Full Text] [Related]
12. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo.
Johnson TA; Chereji RV; Stavreva DA; Morris SA; Hager GL; Clark DJ
Nucleic Acids Res; 2018 Jan; 46(1):203-214. PubMed ID: 29126175
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.
Verhoog NJ; Du Toit A; Avenant C; Hapgood JP
J Biol Chem; 2011 Jun; 286(22):19297-310. PubMed ID: 21474440
[TBL] [Abstract][Full Text] [Related]
14. Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS.
Verheggen MM; van Hal PT; Adriaansen-Soeting PW; Goense BJ; Hoogsteden HC; Brinkmann AO; Versnel MA
Eur Respir J; 1996 Oct; 9(10):2036-43. PubMed ID: 8902464
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-related methyltransferase 1 (Merm1) represses the methyltransferase activity of Dnmt3a and facilitates RNA polymerase I transcriptional elongation.
Lyu G; Zong L; Zhang C; Huang X; Xie W; Fang J; Guan Y; Zhang L; Ni T; Gu J; Tao W
J Mol Cell Biol; 2019 Jan; 11(1):78-90. PubMed ID: 30535232
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells.
Bing Y; Zhu S; Yu G; Li T; Liu W; Li C; Wang Y; Qi H; Guo T; Yuan Y; He Y; Liu Z; Liu Q
J Biol Chem; 2014 Nov; 289(47):32639-55. PubMed ID: 25271158
[TBL] [Abstract][Full Text] [Related]
17. Role of enhanced glucocorticoid receptor sensitivity in inflammation in PTSD: insights from computational model for circadian-neuroendocrine-immune interactions.
Somvanshi PR; Mellon SH; Yehuda R; Flory JD; Makotkine I; Bierer L; Marmar C; Jett M; Doyle FJ
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E48-E66. PubMed ID: 32315214
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase interacts with the glucocorticoid receptor upon TLR2 activation.
Arancibia S; Benítez D; Núñez LE; Jewell CM; Langjahr P; Candia E; Zapata-Torres G; Cidlowski JA; González MJ; Hermoso MA
J Cell Mol Med; 2011 Feb; 15(2):339-49. PubMed ID: 19874421
[TBL] [Abstract][Full Text] [Related]
19. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter.
Sharma D; Bhave S; Gregg E; Uht R
Mol Endocrinol; 2013 Jul; 27(7):1142-52. PubMed ID: 23671328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
